%0 Journal Article
%T The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation
%A Hiroya Taniguchi
%A Kazunori Honda
%A Kei Muro
%A Keiji Sugiyama
%A Masahiro Tajika
%A Masashi Ando
%A Seiichiro Mitani
%A Shigenori Kadowaki
%A Takashi Ura
%A Toshiki Masuishi
%A Yasushi Yatabe
%A Yukiya Narita
%J Archive of "Therapeutic Advances in Medical Oncology".
%D 2019
%R 10.1177/1758835918820298
%X BRAF (v-raf murine sarcoma viral oncogene homolog B1) V600E mutant colorectal cancer is associated with short survival. Recently, clinical trials have been conducted to improve outcomes of second or later lines of chemotherapy. However, there is a paucity of reference data pertaining to outcomes of second-line chemotherapy and prognostic factors that are relevant only to BRAF mutant patients
%K BRAF V600E mutation
%K Glasgow Prognostic Score
%K metastatic colorectal cancer
%K second-line chemotherapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348546/